Detection of Residual Pulmonary Vascular Obstruction by Ventilation-Perfusion Lung Scan Late After a First Pulmonary Embolism

Abstract The long-term impact of persistent pulmonary vascular obstruction after pulmonary embolism (PE) remains unknown. Based on ventilation-perfusion (V-Q) lung scan performed at discharge and 3 months after a first pulmonary embolism (PE), we aimed to investigate the prognostic value on 5-year a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2017-06, Vol.119 (11), p.1883-1889
Hauptverfasser: Chopard, Romain, MD, PhD, Genet, Bruno, MD, Ecarnot, Fiona, MSc, Chatot, Marion, MD, Napporn, Gabriel, MD, Hyvert, Agnes, MD, Didier-Petit, Katy, MD, Schiele, Francois, MD, PhD, Meneveau, Nicolas, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract The long-term impact of persistent pulmonary vascular obstruction after pulmonary embolism (PE) remains unknown. Based on ventilation-perfusion (V-Q) lung scan performed at discharge and 3 months after a first pulmonary embolism (PE), we aimed to investigate the prognostic value on 5-year adverse events of (1) residual pulmonary vascular obstruction (RPVO) at discharge (DIS-RPVO), (2) RPVO at 3 months (3M-RPVO), and (3) relative change in RPVO between the two scans (RC-RPVO). We performed a prospective, multicenter cohort study from 01/2007 to 12/2009 including patients who survived at least 3 months after a PE. RC-RPVO was defined as (DIS-RPVO – 3M-RPVO)/DIS-RPVO. The primary endpoint was a combined endpoint at 5 years, composed of all-cause death, recurrent venous thromboembolism, chronic thromboembolic pulmonary hypertension, heart failure and rehospitalization for cardiac causes. Receiver-operating characteristic curves were computed to define thresholds of DIS-RPVO, 3M-RPVO and RC-RPVO predictive of the primary combined end-point at 5 years. Overall, 241 patients were included (high-risk PE:11.2%, intermediate-risk PE:51.8%, low-risk PE:37%). Mean DIS-RPVO was 27.9±15.1%, mean 3M-RPVO was 10.3±10.8% and mean RC-RPVO was 61.7±33.4%. At 5 years, 112 patients (46.5%) experienced the combined end-point. Both 3M-RPVO≥15% and RC-RPVO≤37.5% were independently related to the occurrence of the combined end-point at 5 years (p=0.01 and, p=0.02, respectively). DIS-RPVO did not predict long-term adverse events. In conclusion, RC-RPVO≤37.5% and 3M-RPVO≥15% were independently related to the occurrence of adverse events 5 years after a first PE.
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2017.03.002